Not applicableEnded earlyNCT02228421What this trial is testingStudy to Evaluate Real-world Pharmacoeconomics of Crizotinib in NSCLC PatientsWho this might be right forNon-small Cell Lung Cancer Metastatic PeriPharm 29
Large-scale testing (Phase 3)Ended earlyNCT00516685What this trial is testingVaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer (NSCLC) Stages IIIB/IVWho this might be right forNon-small-cell Lung Cancer (NSCLC) Stage IIIb/IV Bioven Sdn. Bhd. 230
Large-scale testing (Phase 3)Looking for participantsNCT06745908What this trial is testingClinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint InWho this might be right forNSCLC Stage IV ImmunityBio, Inc. 507
Not applicableUnknownNCT06000358What this trial is testingThe Effect of Combined Cryotherapy and Immunotherapy on Systemic T Cell Changes and Clinical Outcomes in Metastatic Non-small Cell Lung CancerWho this might be right forLung Cancer Stage IV Lithuanian University of Health Sciences 120
Testing effectiveness (Phase 2)Ended earlyNCT00040768What this trial is testingBortezomib in Treating Patients With Advanced Non-small Cell Lung CancerWho this might be right forRecurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT00287989What this trial is testingErlotinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III, Stage IV, or Recurrent Non-Small Cell Lung CancerWho this might be right forLung Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 86
Early research (Phase 1)Study completedNCT06525246What this trial is testingStudy of ONO-7475 in Combination With Osimertinib in EGFR Gene Mutation-positive Non-small Cell Lung CancerWho this might be right forStage IIIB Non-small Cell Lung CancerStage IIIC Non-Small Cell Lung CancerStage IV Non-small Cell Lung Cancer+2 more Ono Pharmaceutical Co., Ltd. 78
Early research (Phase 1)Study completedNCT00327288What this trial is testingSafety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer PatientsWho this might be right forNon-small Cell Lung CancerBreast CancerProstate Cancer AmpliMed Corporation 34
Not applicableStudy completedNCT01004601What this trial is testingLow Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer Chang Gung Memorial Hospital 179
Testing effectiveness (Phase 2)UnknownNCT02669719What this trial is testingCellular Immunotherapy Synergize Chemotherapy in Patients With Stage IV NSCLCWho this might be right forNon Small Cell Lung Cancer Shanghai Chest Hospital 70
Early research (Phase 1)Study completedNCT00503568What this trial is testingVaccine Therapy in Treating Patients With Stage III, Stage IV, or Relapsed Non-Small Cell Lung Cancer Treated With First-Line ChemotherapyWho this might be right forLung Cancer University of Miami 19
Large-scale testing (Phase 3)Ended earlyNCT00473889What this trial is testingA Clinical Trial of Vorinostat (MK0683, SAHA) in Combination With FDA Approved Cancer Drugs in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)(0683-056)Who this might be right forStage IIIB or IV Non-Small Cell Lung Cancer Merck Sharp & Dohme LLC 253
Not applicableUnknownNCT04636775What this trial is testingMicrobiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC)Who this might be right forNSCLC Stage IVNSCLC, Recurrent Jun Zhang, MD, PhD 46
Not applicableStudy completedNCT01015963What this trial is testingStudying DNA in Tissue Samples From Caucasian and African-American Cancer Patients Who Received Docetaxel on Clinical Trial CLB-9871Who this might be right forBladder CancerBreast CancerHead and Neck Cancer+2 more Alliance for Clinical Trials in Oncology 69
Testing effectiveness (Phase 2)UnknownNCT03987087What this trial is testingStudy of Primary Tumor Radiotherapy for Patients With MPE Stage IV NSCLCWho this might be right forMalignant Pleural EffusionNonsmall Cell Lung Cancer, Stage IV Guizhou Medical University 68
Early research (Phase 1)Study completedNCT00004604What this trial is testingBiological Therapy in Treating Patients With Metastatic CancerWho this might be right forBreast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more Duke University 24
Large-scale testing (Phase 3)Study completedNCT02031744What this trial is testingThe Efficacy and Safety of MetMAb Combined With Tarceva in Patients With Met-Positive Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Hoffmann-La Roche 530
Testing effectiveness (Phase 2)Active Not RecruitingNCT04625647What this trial is testingTesting the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)Who this might be right forLung AdenocarcinomaLung Non-Small Cell CarcinomaRecurrent Lung Non-Squamous Non-Small Cell Carcinoma+3 more SWOG Cancer Research Network 116
Early research (Phase 1)Study completedNCT00866528What this trial is testingStudy of Pazopanib and Paclitaxel in Advanced Non-small Cell Lung CancerWho this might be right forLung Cancer, Non-Small Cell GlaxoSmithKline 30
Not applicableStudy completedNCT00823732What this trial is testingEffects of Palliative Care on Quality of Life and Symptom Control in Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryWho this might be right forLung Cancer City of Hope Medical Center 280